ReviewEuropean journal of immunology2025
Insights Into Complex Murine Models of Allergy and Anaphylaxis: The Central Role of IgE and Mast Cells in Advancing Human Therapies.
Review in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.Frontiers in allergy · 2026Article
- Insights Into Complex Murine Models of Allergy and Anaphylaxis: The Central Role of IgE and Mast Cells in Advancing Human Therapies.European journal of immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin E (IgE)-mediated immediate hypersensitivity reactions underlie most allergic responses and are characterized by rapid mast cell (MC) activation and the subsequent release of mediators. These processes have been studied in rodent models via IgE or allergen sensitization, which replicate essential aspects of human allergic responses. Because allergic diseases exhibit diverse clinical manifestations, varying in phenotype, allergen specificity, immune response, and pathophysiological mechanisms, it is essential to employ a variety of models to comprehensively address distinct aspects of allergic responses and mechanisms. Allergic responses in mouse models can vary depending on factors such as experimental condition and murine strain, and these variations influence the ability of the model to reflect manifestations of human disease. This review aimed to summarize the characteristics of various murine allergy models, primarily focusing on wild-type strains, highlighting the impact of sensitization strategy, administration route, and murine strain on allergic disease outcomes. Given the pivotal role of MCs in allergic disease, achieving a deeper understanding of their characteristics across models is expected to enhance the applicability of these models and facilitate the development of MC-targeted therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.